Pfizer: 1QFY02 net zooms 33% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pfizer: 1QFY02 net zooms 33%

Apr 2, 2001

Pfizer India has reported a 33% jump in its bottomline during the first quarter ended February 28, 2001. A 44% jump in other income has been partly responsible for the growth in bottomline.

(Rs m) 1QFY01 1QFY02 Change
Gross Sales 722 829 14.9%
Other Income 88 127 44.9%
Expenditure 683 793 16.0%
Operating Profit (EBDIT) 38 36 -5.2%
Operating Profit Margin (%) 5.3% 4.4%  
Interest 1 1 30.0%
Depreciation 13 16 27.6%
Profit before Tax 112 146 29.9%
Tax 47 58 25.4%
Profit after Tax/(Loss) 66 88 33.1%
Net profit margin (%) 9.1% 10.6%  
No. of Shares (eoy) (m) 11.7 23.4  
Earnings per share* 22.5 15.0  
(annualised)      
Diluted Earnings per share* 11.2 15.0  
(annualised)      
Current P/e ratio   36.7  

Out of the total other income of Rs 127 m, the management has stated that Rs 104 m is service income (previous year Rs 69 m). The company's gross sales recorded an improvement of 15% during the period.

Its key brand Becousules (its B–complex vitamin) was brought under price control early last year. Becousules contributes around 20% to the company’s turnover and the National Pharmaceutical Pricing Authority had reduced its prices by 30%. But for this, Pfizer's topline growth would have been higher.

The $16.9 bn Pfizer Inc. is next only to Glaxo–Smithkline in the global pharma sweepstakes. With the takeover of $ 9 bn Warner Lambert, it has emerged as the largest US company. In India however, six brands viz. Becousules, Lorex, Protinex, Dolonex, Terramycin and Minipress XL account for 80% of the company’s sales.

However, the company’s Hepatitis B brand ‘Hepashield’ continues to do well. This has helped the company to reduce its dependence on its six brands. Pfizer had launched Hepashield in March 2000 under a co-marketing deal with Shanta Biotech. Smithkline Pharma had been the leader in this segment with its brand Engerix B.

The stock trades at Rs 549, a P/e multiple of 36.7 times its annualised 1QFY02 earnings.

Equitymaster requests your view! Post a comment on "Pfizer: 1QFY02 net zooms 33% ". Click here!

  

More Views on News

PFIZER 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PFIZER for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year (Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Dec 8, 2021 01:11 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS